BAMCO INC /NY/ - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 279 filers reported holding CYTOKINETICS INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.

Quarter-by-quarter ownership
BAMCO INC /NY/ ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q3 2023$736,500
-43.6%
25,000
-37.5%
0.00%
-50.0%
Q2 2023$1,304,800
-22.9%
40,000
-16.8%
0.00%
-20.0%
Q1 2023$1,692,639
-16.2%
48,100
+9.1%
0.01%
-28.6%
Q4 2022$2,020,662
+48.9%
44,100
+57.5%
0.01%
+75.0%
Q3 2022$1,357,000
+23.4%
28,0000.0%0.00%0.0%
Q2 2022$1,100,000
-21.4%
28,000
-26.3%
0.00%
+33.3%
Q1 2022$1,399,000
-36.1%
38,000
-20.8%
0.00%
-40.0%
Q4 2021$2,188,00048,0000.01%
Other shareholders
CYTOKINETICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
BVF INC/IL 2,106,989$14,159,0002.50%
Healthcare Value Capital, LLC 100,000$672,0000.71%
First Light Asset Management, LLC 218,792$1,470,0000.69%
IRONWOOD INVESTMENT MANAGEMENT LLC 435,202$2,925,0000.67%
TFS CAPITAL LLC 899,951$6,048,0000.59%
SPHERA FUNDS MANAGEMENT LTD. 422,250$2,838,0000.28%
ALGERT GLOBAL LLC 73,181$492,0000.27%
LANSDOWNE PARTNERS (UK) LLP 2,321,865$15,603,0000.13%
Leisure Capital Management 17,567$118,0000.12%
Rotella Capital Management, Inc. 15,778$106,0000.09%
View complete list of CYTOKINETICS INC shareholders